To improve patients´ quality of life has been the source of Ana Gabriela Galindo´s motivation, which has led her to develop a more advanced control technique that is a viable alternative to facilitate treatment.

The current trend is consists of control tools (also known as controllers) that use a very large number of parameters which must be measured in each patient, introducing the risk of overdose when the parameters of each patient vary as well as a high degree of uncertainty. Ana Gabriela has designed a control tool which is insensitive to these parameters and allows the dosage to be automated and facilitates patient treatments. Throughout a sensor associated with a controller, the system captures real-time data relating to the glucose concentration in the blood of each patient and customizes the dosage accordingly.

The use of these more advanced controllers bring an improvement in the quality of life of patients while reducing the cost of treatment, because it uses only the amount of medication required.

This system not only has great potential in terms of the automation of insulin dosages but may also be applied to early diagnosis, minimizing the side effects of collateral medications such as anesthesia and reduce the cost of some therapies."